STOGEL STEVEN J 4
4 · ACCENTIA BIOPHARMACEUTICALS INC · Filed Jun 23, 2006
Insider Transaction Report
Form 4
STOGEL STEVEN J
Director
Transactions
- Other
Common Stock
2006-04-03$8.00/sh+2,084$16,672→ 434,243 total
Footnotes (1)
- [F1]Represents the receipt of shares of common stock in lieu of accrued but unpaid dividends on the Company's former Series E Convertible Preferred Stock at a price of $8.00 a share.